Literature DB >> 4889468

Clinical studies with a new rifamycin derivative.

H D Cohn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4889468

Source DB:  PubMed          Journal:  J Clin Pharmacol J New Drugs        ISSN: 0095-9863


× No keyword cloud information.
  7 in total

1.  Effect of rifampicin and isoniazid on liver function.

Authors:  S Lal; S N Singhal; D M Burley; G Crossley
Journal:  Br Med J       Date:  1972-01-15

Review 2.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

4.  Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein.

Authors:  S Kenwright; A J Levi
Journal:  Gut       Date:  1974-03       Impact factor: 23.059

5.  Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.

Authors:  G Acocella; L Bonollo; M Garimoldi; M Mainardi; L T Tenconi; F B Nicolis
Journal:  Gut       Date:  1972-01       Impact factor: 23.059

6.  The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.

Authors:  B W Allen; G A Ellard; P T Gammon; R C King; A C McDougall; R J Rees; A G Weddell
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

Review 7.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.